NASDAQ:CTMX

Cytomx Therapeutics Stock Predictions

etoro logo Buy CTMX
*Your capital is at risk
$3.16
-0.290 (-8.41%)
At Close: Jun 02, 2026
Currently predicting for Thu, 4 Jun 2026

CTMX Prediction Chart

CTMX Predictions History

Latest community submissions for CTMX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 20, 2026 $5.25 -2.66% $5.37 V 97.71% 1
Jan 20, 2026 $5.30 -1.66% $5.37 V 98.71% 2
Skagitqg Skagitqg Merchant
Jan 20, 2026 Bullish $5.37 V 0
Jan 12, 2026 $4.24 -2.45% $4.34 V 97.77% 1
Jan 12, 2026 $4.28 -1.53% $4.34 V 98.69% 2
Jan 12, 2026 $5.12 +17.70% $4.34 X 82.03% 0
Jan 8, 2026 $4.19 -2.55% $4.26 V 98.36% 1
Jan 8, 2026 $4.23 -1.59% $4.26 V 99.33% 4
Skagitqg Skagitqg Merchant
Jan 8, 2026 Bullish $4.26 V 0
Dec 18, 2025 Bullish $3.88 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CTMX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CYTOMX THERAPEUTICS
CytomX Therapeutics
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE